Insufficient scRNA-seq data for expression of CHRNG at single-cell level.
Insufficient scRNA-seq data for expression of CHRNG at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
muscle | 100% | 2242.04 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 97% | 9.73 | 233 / 241 | 0% | 0 | 0 / 0 |
skin | 76% | 5.82 | 1372 / 1809 | 0% | 0.00 | 1 / 472 |
prostate | 71% | 15.32 | 175 / 245 | 1% | 0.02 | 4 / 502 |
stomach | 70% | 4.60 | 253 / 359 | 1% | 0.02 | 4 / 286 |
peripheral blood | 71% | 4.06 | 660 / 929 | 0% | 0 | 0 / 0 |
ovary | 64% | 2.72 | 115 / 180 | 2% | 0.10 | 7 / 430 |
lung | 64% | 2.85 | 371 / 578 | 1% | 0.02 | 10 / 1155 |
breast | 64% | 3.72 | 295 / 459 | 1% | 0.01 | 8 / 1118 |
thymus | 64% | 3.05 | 415 / 653 | 1% | 0.03 | 8 / 605 |
intestine | 64% | 3.98 | 618 / 966 | 0% | 0.01 | 1 / 527 |
bladder | 62% | 2.14 | 13 / 21 | 1% | 0.02 | 4 / 504 |
adipose | 62% | 3.20 | 750 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 60% | 2.34 | 196 / 328 | 1% | 0.01 | 2 / 178 |
kidney | 58% | 2.67 | 52 / 89 | 0% | 0.00 | 1 / 901 |
esophagus | 57% | 3.10 | 818 / 1445 | 0% | 0 | 0 / 183 |
liver | 54% | 2.35 | 123 / 226 | 0% | 0 | 0 / 406 |
uterus | 49% | 1.78 | 83 / 170 | 5% | 1.16 | 23 / 459 |
adrenal gland | 52% | 2.04 | 134 / 258 | 0% | 0 | 0 / 230 |
brain | 44% | 1.58 | 1164 / 2642 | 0% | 0.01 | 1 / 705 |
blood vessel | 32% | 2.15 | 427 / 1335 | 0% | 0 | 0 / 0 |
heart | 32% | 0.99 | 273 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0034220 | Biological process | monoatomic ion transmembrane transport |
GO_0095500 | Biological process | acetylcholine receptor signaling pathway |
GO_0051899 | Biological process | membrane depolarization |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0006936 | Biological process | muscle contraction |
GO_0007271 | Biological process | synaptic transmission, cholinergic |
GO_0060079 | Biological process | excitatory postsynaptic potential |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0005892 | Cellular component | acetylcholine-gated channel complex |
GO_0045202 | Cellular component | synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0043005 | Cellular component | neuron projection |
GO_0022848 | Molecular function | acetylcholine-gated monoatomic cation-selective channel activity |
GO_1904315 | Molecular function | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential |
GO_0015267 | Molecular function | channel activity |
GO_0015464 | Molecular function | acetylcholine receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CHRNG |
Protein name | Acetylcholine receptor subunit gamma |
Synonyms | ACHRG |
Description | FUNCTION: After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. FUNCTION: After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. . |
Accessions | ENST00000651502.1 [P07510-1] ENST00000389492.3 [P07510-2] A0A6F7YAP6 P07510 |